These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 24960652)

  • 1. Management of bleeding in acquired haemophilia A with recombinant activated factor VII: does one size fit all? A report of four cases.
    Di Capua M; Coppola A; Nardo A; Cimino E; Di Minno MN; Tufano A; Mormile R; Burzo ML; Di Minno G; Cerbone AM
    Blood Transfus; 2015 Apr; 13(2):328-32. PubMed ID: 24960652
    [No Abstract]   [Full Text] [Related]  

  • 2. Recombinant activated factor VII in the treatment of bleeding episodes in patients with inherited and acquired bleeding disorders.
    Hedner U; Glazer S; Falch J
    Transfus Med Rev; 1993 Apr; 7(2):78-83. PubMed ID: 8481602
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Controlling acute bleeding episodes with recombinant factor VIIa in haemophiliacs with inhibitor: continuous infusion and bolus injection.
    Chuansumrit A; Isarangkura P; Angchaisuksiri P; Sriudomporn N; Tanpowpong K; Hathirat P; Jorgensen LN
    Haemophilia; 2000 Mar; 6(2):61-5. PubMed ID: 10781189
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical efficacy of recombinant activated factor VII (rFVIIa) during acute bleeding episode and surgery in a patient with acquired hemophilia A with high inhibitor titer.
    Franchini M; Capra F; Capelli C; de Maria E; Lippi G; Gandini G
    Haematologica; 2001 Apr; 86(4):E12. PubMed ID: 11325664
    [No Abstract]   [Full Text] [Related]  

  • 5. Relationship between factor VII activity and clinical efficacy of recombinant factor VIIa given by continuous infusion to patients with factor VIII inhibitors.
    Santagostino E; Morfini M; Rocino A; Baudo F; Scaraggi FA; Gringeri A
    Thromb Haemost; 2001 Oct; 86(4):954-8. PubMed ID: 11686352
    [TBL] [Abstract][Full Text] [Related]  

  • 6. How we use recombinant activated Factor VII in patients with haemophilia A or B complicated by inhibitors. Working group of hematology experts from Australia and New Zealand, Melbourne, April 2011.
    Brown SA; Barnes C; Curtin J; Dunkley S; Ockelford P; Phillips J; Rowell J; Smith M; Tran H;
    Intern Med J; 2012 Nov; 42(11):1243-50. PubMed ID: 23157518
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Recombinant factor VIIa in joint and muscle bleeding episodes.
    Bech RM
    Haemostasis; 1996; 26 Suppl 1():135-8. PubMed ID: 8904188
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Results of the WIRK prospective, non-interventional observational study of recombinant activated factor VII (rFVIIa) in patients with congenital haemophilia with inhibitors and other bleeding disorders.
    Birschmann I; Klamroth R; Eichler H; Schenk J; Kirchmaier CM; Halimeh S
    Haemophilia; 2013 Sep; 19(5):679-85. PubMed ID: 23647644
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treatment of acute bleeding in acquired haemophilia A with recombinant activated factor VII: analysis of 10-year Japanese postmarketing surveillance data.
    Amano K; Seita I; Higasa S; Sawada A; Kuwahara M; Shima M
    Haemophilia; 2017 Jan; 23(1):50-58. PubMed ID: 27457022
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The use of combination FEIBA and rFVIIa bypassing therapy, with TEG profiling, in uncontrollable bleeding associated with acquired haemophilia A.
    Dunkley SM; Yang K
    Haemophilia; 2009 May; 15(3):828-30. PubMed ID: 19444979
    [No Abstract]   [Full Text] [Related]  

  • 11. Continuous infusion of recombinant factor VIIa: continue or not?
    Ewenstein BM
    Thromb Haemost; 2001 Oct; 86(4):942-4. PubMed ID: 11686349
    [No Abstract]   [Full Text] [Related]  

  • 12. The treatment of bleeding in acquired haemophilia with recombinant factor VIIa: a multicentre study.
    Hay CR; Negrier C; Ludlam CA
    Thromb Haemost; 1997 Dec; 78(6):1463-7. PubMed ID: 9423795
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Acquired haemophilia in a patient with discoid lupus.
    Appelmann I; Biermann C; Hartig I; Berdel WE; Mesters R
    Ann Hematol; 2011 Jan; 90(1):119-20. PubMed ID: 20467746
    [No Abstract]   [Full Text] [Related]  

  • 14. Recombinant activated factor VIIa in uncontrolled bleeding: a haemostasis laboratory study in non-haemophilia patients.
    Brandsborg S; Sørensen B; Poulsen LH; Ingerslev J
    Blood Coagul Fibrinolysis; 2006 Jun; 17(4):241-9. PubMed ID: 16651865
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Recombinant factor VIIa (eptacog alfa): a pharmacoeconomic review of its use in haemophilia in patients with inhibitors to clotting factors VIII or IX.
    Lyseng-Williamson KA; Plosker GL
    Pharmacoeconomics; 2007; 25(12):1007-29. PubMed ID: 18047387
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Assessment of individual dose utilization vs. physician prescribing recommendations for recombinant activated factor VII (rFVIIa) in paediatric and adult patients with congenital haemophilia and alloantibody inhibitors (CHwI): the Dosing Observational Study in Hemophilia (DOSE).
    Gruppo RA; Kessler CM; Neufeld EJ; Cooper DL
    Haemophilia; 2013 Jul; 19(4):524-32. PubMed ID: 23551918
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Recombinant factor VIIa and factor VIII treatment for acquired factor VIII deficiency: a case of repeated thrombotic endotracheal occlusion in a mechanically ventilated patient.
    Lauer S; Westphal M; Fischer LG; Meissner A; Van Aken H; Freise H
    Crit Care; 2011; 15(2):407. PubMed ID: 21418550
    [No Abstract]   [Full Text] [Related]  

  • 18. rFVIIa and obstructive hydronephrosis.
    Louie R; Thomas B; Irwin R
    Pediatr Blood Cancer; 2008 Feb; 50(2):431. PubMed ID: 17387704
    [No Abstract]   [Full Text] [Related]  

  • 19. Elective surgery on factor VIII inhibitor patients using continuous infusion of recombinant activated factor VII: plasma factor VII activity of 10 IU/ml is associated with an increased incidence of bleeding.
    Smith MP; Ludlam CA; Collins PW; Hay CR; Wilde JT; Grigeri A; Melsen T; Savidge GF
    Thromb Haemost; 2001 Oct; 86(4):949-53. PubMed ID: 11686351
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Successful management of massive intraperitoneal bleeding in a hemophilia A patient with inhibitor by surgical debridement of the incomplete hematoma and administration of recombinant factor VIII and activated factor VII.
    Koyama T; Nagao T; Tsunozaki H; Arai M; Miura O
    Pathophysiol Haemost Thromb; 2006; 35(5):405-7. PubMed ID: 17230044
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.